摘要 |
The current invention discloses a medicament and its use in a method for therapeutically managing hyperproliferative diseases of the skin in particular, psoriasis of the skin, scalp and nails. The medicament includes a dual inhibitor of 5-lipoxygenase and human leukocyte elastase singly or in combination with a bioavailable organic selenium nutritional supplement. In particular, the medicament includes (a) an oral formulation of acetyl-11-keto-beta-boswellic acid in combination with a bioavailable organic selenium supplement dispersed in a pharmaceutical carrier; and (b) a topical formulation of acetyl-11-keto-beta-boswellic acid alone dispersed in a pharmaceutical carrier. The said medicament is shown to be effective for the therapeutic management of clinical psoriasis based on its ability to (i) provide relief of clinical symptoms and (ii) the ability to clear psoriatic lesions as evaluated in 3 months, open, prospective, multi-center, phase III Clinical study.
|